McFarlane Neil F. (CIK 0001681098)

Latest company ownership

Shares held
50,000
Last filed at
Oct 10, 2025
Confidence Score
34.5
2025Q4
Confidence Score History
2025Q1 2025Q4
Shares held
26,988
Last filed at
May 16, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 10, 2025 Oct 10, 2025 ZEVRA THERAPEUTICS, INC. CEO Sell 28.8 -19,500 -8.07% ✓ $210.9K
Feb 13, 2025 Feb 14, 2025 ZEVRA THERAPEUTICS, INC. CEO Sell 7.5 -91,817 -32.41% ✓ $727.4K
May 15, 2019 May 16, 2019 Travere Therapeutics, Inc. COO Sell 36.3 -1,968 -6.80% ✓ $35.9K
Dec 20, 2018 Dec 21, 2018 Travere Therapeutics, Inc. COO Sell 10.0 -11,125 -27.76% ✓ $248.3K
Nov 14, 2018 Nov 16, 2018 Travere Therapeutics, Inc. COO Sell 10.0 -10,000 -25.99% ✓ $237.3K
Aug 16, 2017 Aug 17, 2017 Travere Therapeutics, Inc. COO Sell 26.3 -1,378 -9.19% ✗ $31K